Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$817.4M
-4.1% from 2023
Prescriptions
102K
$7,980.93 per claim
Patients
14K
9,400 prescribers
Total spending, 2024
$817.6M
$57,596.34 per patient
Medicare prescription drug plans paid $817.4M for Cosentyx Sensoready (2 Pens) in 2024, for 102,416 prescriptions and refills to 14,191 patients (down 4.1% from 2023). The average cost per claim was $7,980.93.
California had the highest Medicare cost for Cosentyx Sensoready (2 Pens) in 2024: $100.6M for 15,633 claims, followed by Florida ($58.2M).
Michael M Rezaian, rheumatology in Martinsburg, WV, had the highest Medicare cost for Cosentyx Sensoready (2 Pens) in 2024: 232 claims costing $1.9M.
Cosentyx Sensoready (2 Pens) is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Michael M Rezaian Martinsburg, WV | Rheumatology | 232 | 46 | $1.9M |
| Jamiel Ramos San Antonio, TX | Nurse Practitioner | 235 | 39 | $1.9M |
| Laura N Howe |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 9,214 | 108,224 | 14,428 | $852.4M |
| 2024 | 9,400 | 102,416 | 14,191 | $817.4M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Rheumatology |
| 195 |
| 25 |
| $1.5M |
| Kevin M Crawford Seymour, IN | Dermatology | 160 | 22 | $1.4M |
| Kelsey E Nadeau Presque Isle, ME | Nurse Practitioner | 173 | 18 | $1.4M |
| Kyla Lokitz Shreveport, LA | Internal Medicine | 136 | 21 | $1.1M |
| Alexandra Charrow Boston, MA | Dermatology | 98 | 11 | $1.0M |
| Ronald L George Jr. Wilmington, NC | Rheumatology | 123 | 27 | $994K |
| Naiara Alvarez Harlingen, TX | Rheumatology | 128 | 17 | $941K |
| Justina J Tseng Redding, CA | Rheumatology | 111 | 12 | $926K |
| Malik C Spady Covington, LA | Rheumatology | 117 | 20 | $909K |
| Khanh Ngoc C Ton Nu Westminster, CA | Physician Assistant | 106 | 16 | $821K |
| Gary E Solomon New York, NY | Internal Medicine | 80 | Under 11 | $782K |
| Tien Q Nguyen Fountain Valley, CA | Dermatology | 105 | 14 | $766K |
| George S Drew Marion, OH | Dermatology | 91 | 11 | $752K |
| Ana Goico Alburquerque Terre Haute, IN | Rheumatology | 103 | Under 11 | $752K |
| Jerald E Hurdle Waterville, ME | Interventional Pain Management | 97 | Under 11 | $740K |
| Matthew Mullen Mountain Brk, AL | Rheumatology | 80 | Under 11 | $737K |
| Jennifer S Vega South Miami, FL | Nurse Practitioner | 85 | 11 | $733K |
| Barry I Resnik Aventura, FL | Dermatology | 53 | Under 11 | $709K |
| Zhiqian Wang Lakewood, WA | Rheumatology | 90 | 13 | $702K |
| James Krell Birmingham, AL | Dermatology | 87 | Under 11 | $696K |
| Mayra G Oberto-Medina Coon Rapids, MN | Internal Medicine | 79 | 13 | $692K |
| Joseph Devich Jr. Pittsburgh, PA | Rheumatology | 91 | 14 | $668K |
| Ya Ju Chang New York, NY | Rheumatology | 83 | Under 11 | $659K |
| Spending |
|---|
| Novartis NVS | 102,445 | $817.6M |